Kumamoto, Japan

Ryuichi Sakamoto


 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 18(Granted Patents)


Location History:

  • Kikuchi, JP (2012 - 2014)
  • Kumamoto, JP (2016 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ryuichi Sakamoto: Innovator in Vaccine Development

Introduction

Ryuichi Sakamoto is a notable inventor hailing from Kumamoto, Japan. He has made significant contributions to the field of vaccine development, particularly in the area of avian health. With a total of 5 patents to his name, Sakamoto's work has the potential to impact poultry health and production.

Latest Patents

Sakamoto's latest patents include an LPS vaccine, which is a vaccine composition for birds that utilizes a structure containing O-antigen derived from Gram-negative bacteria. This innovative approach alleviates inoculation reactions and reduces the amount of injection required compared to conventional whole-cell vaccines. Additionally, he has developed a prophylactic vaccine against egg drop syndrome (EDS), which effectively prevents EDS and can be stably supplied. This vaccine contains a fused protein that enhances its efficacy against the EDS virus.

Career Highlights

Throughout his career, Sakamoto has worked with reputable organizations such as the Chemo-sero-therapeutic Research Institute and Km Biologics Co., Ltd. His work in these institutions has allowed him to focus on developing advanced vaccine solutions for avian diseases.

Collaborations

Sakamoto has collaborated with esteemed colleagues, including Masashi Sakaguchi and Toshihiro Ushijima. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Ryuichi Sakamoto's innovative contributions to vaccine development demonstrate his commitment to improving avian health. His patents reflect a significant advancement in the field, showcasing his expertise and dedication to research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…